Statement Of Changes In Equity [Abstract]

Sopharma Trading AD - Filing #6022483

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transfer between revaluation surplus and retained earnings, equity
- BGN
- BGN
- BGN
62,000 BGN
- BGN
62,000 BGN
- BGN
Increase (decrease) through transfer to statutory reserve, equity
- BGN
1 684 BGN
- BGN
16 832 BGN
15 148 BGN
- BGN
- BGN
- BGN
524,000 BGN
- BGN
4 718 BGN
- BGN
5 242 BGN
- BGN
Increase (decrease) through appropriation of retained earnings, equity
- BGN
1 684 BGN
- BGN
16 832 BGN
15 148 BGN
- BGN
- BGN
- BGN
524,000 BGN
- BGN
4 718 BGN
- BGN
5 242 BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.